These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32170481)

  • 1. Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.
    Veld JV; Wisselink DD; Amelung FJ; Consten ECJ; de Wilt JHW; de Hingh I; Bemelman WA; van Hooft JE; Tanis PJ;
    Ann Surg Oncol; 2020 Aug; 27(8):2762-2773. PubMed ID: 32170481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
    Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
    Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
    Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
    Rijken A; Pape M; Simkens GA; de Hingh IHJT; Luyer MDP; van Sandick JW; van Laarhoven HWM; Verhoeven RHA; van Erning FN
    Int J Cancer; 2024 Mar; 154(6):992-1002. PubMed ID: 37916797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence.
    Le VH; Thornblade L; Ituarte PHG; Lai LL; Melstrom KA
    J Surg Oncol; 2021 Feb; 123(2):622-629. PubMed ID: 33616972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer.
    Segelman J; Granath F; Holm T; Machado M; Mahteme H; Martling A
    Br J Surg; 2012 May; 99(5):699-705. PubMed ID: 22287157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for appendiceal and colorectal peritoneal metastases.
    Enblad M; Graf W; Birgisson H
    Eur J Surg Oncol; 2018 Jul; 44(7):997-1005. PubMed ID: 29576463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study.
    Bastiaenen VP; Aalbers AGJ; Arjona-Sánchez A; Bellato V; van der Bilt JDW; D'Hoore AD; Espinosa-Redondo E; Klaver CEL; Nagtegaal ID; van Ramshorst B; van Santvoort HC; Sica GS; Snaebjornsson P; Wasmann KATGM; de Wilt JHW; Wolthuis AM; Tanis PJ
    Eur J Surg Oncol; 2021 Sep; 47(9):2405-2413. PubMed ID: 34030920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher incidence of metachronous advanced neoplasia in patients with synchronous advanced neoplasia and left-sided colorectal resection for colorectal cancer.
    Yabuuchi Y; Imai K; Hotta K; Ito S; Kishida Y; Yamaguchi T; Shiomi A; Kinugasa Y; Yoshida M; Tanaka M; Kawata N; Kakushima N; Takizawa K; Ishiwatari H; Matsubayashi H; Ono H
    Gastrointest Endosc; 2018 Aug; 88(2):348-359.e1. PubMed ID: 29574125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study.
    Ghiringhelli F; Hennequin A; Drouillard A; Lepage C; Faivre J; Bouvier AM
    Dig Liver Dis; 2014 Sep; 46(9):854-8. PubMed ID: 24908575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer.
    Kunitomo A; Ouchi A; Komori K; Kinoshita T; Sato Y; Abe T; Ito S; Sano T; Shimizu Y
    Ann Surg Oncol; 2023 Dec; 30(13):8501-8508. PubMed ID: 37658266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
    Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
    J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer.
    Nagata H; Ishihara S; Hata K; Murono K; Kaneko M; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Watanabe T
    Ann Surg Oncol; 2017 May; 24(5):1269-1280. PubMed ID: 27995451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, oncologic results and risk stratification model for metachronous peritoneal metastases after surgery for pT4 colon cancers: results from an observational retrospective multicentre long-term follow-up study.
    Cerdán-Santacruz C; Cano-Valderrama Ó; Peña Ros E; Serrano Del Moral Á; Pereira Pérez F; Flor Lorente B; Biondo S;
    Tech Coloproctol; 2023 Nov; 27(11):1025-1036. PubMed ID: 37248370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
    Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
    Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study.
    Lurvink RJ; Rijken A; Bakkers C; Lemmens VE; de Reuver PR; Tuynman JB; Kok NF; Nienhuijs SW; van Erning FN; de Hingh IHJT
    Surg Endosc; 2022 Sep; 36(9):6551-6557. PubMed ID: 35059835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer.
    Willem H; Jooste V; Boussari O; Romain G; Bouvier AM
    Eur J Cancer Prev; 2019 May; 28(3):167-172. PubMed ID: 29738323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with extensive regional lymph node involvement (pN2) following potentially curative surgery for colorectal cancer are at increased risk for developing peritoneal metastases: a retrospective single-institution study.
    Bhatt A; Bhamre R; Rohila J; Kalikar V; Desouza A; Saklani A
    Colorectal Dis; 2019 Mar; 21(3):287-296. PubMed ID: 30457185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer.
    Patel A; Williams N; Parsons N; Ali O; Peters F; Ranat R; Shah J; Spector E; Arasaradnam RP
    Int J Colorectal Dis; 2017 Nov; 32(11):1609-1616. PubMed ID: 28828520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.